Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Franklin Covey (FC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Franklin Covey (FC) over the last 16 years, with Q4 2025 value amounting to $15.7 million.

  • Franklin Covey's Cost of Revenue fell 429.92% to $15.7 million in Q4 2025 from the same period last year, while for Nov 2025 it was $62.8 million, marking a year-over-year decrease of 545.21%. This contributed to the annual value of $63.5 million for FY2025, which is 402.5% down from last year.
  • According to the latest figures from Q4 2025, Franklin Covey's Cost of Revenue is $15.7 million, which was down 429.92% from $17.5 million recorded in Q3 2025.
  • In the past 5 years, Franklin Covey's Cost of Revenue ranged from a high of $19.7 million in Q3 2022 and a low of $10.8 million during Q1 2021
  • Over the past 5 years, Franklin Covey's median Cost of Revenue value was $15.7 million (recorded in 2021), while the average stood at $15.6 million.
  • Examining YoY changes over the last 5 years, Franklin Covey's Cost of Revenue showed a top increase of 4072.71% in 2021 and a maximum decrease of 2823.13% in 2021.
  • Quarter analysis of 5 years shows Franklin Covey's Cost of Revenue stood at $13.7 million in 2021, then grew by 21.71% to $16.6 million in 2022, then decreased by 3.04% to $16.1 million in 2023, then increased by 1.57% to $16.4 million in 2024, then dropped by 4.3% to $15.7 million in 2025.
  • Its Cost of Revenue stands at $15.7 million for Q4 2025, versus $17.5 million for Q3 2025 and $15.8 million for Q2 2025.